Home About Us | Members | Register | Brochure | Events  | Management Center Contact UsÖÐÎİæ
 Information
  Program Committee
  Hotel and Venue
  Help & FAQs
  Past Event Report
  Why Speak?
  Who Should Attend?
  Contact Us
 Program
  Key Dates
  Program Track Info
  Full Program
  Social Events
  Public Awareness
  Speakers
 Papers and Poster
  Abstract Information
  Meeting Proceeding
  Submission Guidelines
  2008 Poster Abstracts
 Sponsors
  Your Benefits
  Sponsorship Opportunities
  Sponsor Now!
 Registration
  Registration Information
  Price & Payment
  Registration Now
  Payment and Cancellations
 Press & Media
  Call for Media Partners
  Media Partners List
 Tech Tour
  Schedule of Tour
  Introduction of Shanghai and    Hangzhou
 Join the Mailing List


Support Organization

The Society for Neuro-Oncology
Media Partner
Hindawi Publishing Corp.
Today's Science, Tomorrow's Healthy World
 

European Cancer Prevention Organization becomes Support Organization
 
--------------------------------------------------
The European Journal of Cancer Prevention becomes our media partner
 
--------------------------------------------------
Dr. Axel Ullrich, who discoveries the Oncogene-HER-2/neu has been tentatively confirmed as a speaker at our congress
  --------------------------------------------------
  --------------------------------------------------
  --------------------------------------------------

Early Registration will be extended to December 31, 2007

  --------------------------------------------------
Over 110 overseas speakers have confirmed their participation to the congress
  --------------------------------------------------
Join the fight against cancer
  --------------------------------------------------
Sponsorship and Poster Exhibition Prospectus is available online
Dr. Andrew V. Schally Professor, Veterans Affairs, The Nobel Prize in Physiology or Medicine 1977, USA
Dr. Elwood V. Jensen
Distinguished Professor, University of Cincinnati, 2004 Albert Lasker Medical Award Winner, USA
Dr. Francis P. Crawley
Executive Director, Expert in Ethics of World Health Organization, Belgium
Dr. Eric Lai
Vice President, PGx Experimental Project Coordination and Analysis, GlaxoSmithKline, USA
Dr. Frank Carr
Director of Biologics Research, Antitope Ltd, United Kingdom
Dr. Alan Garen
Professor, Yale University, Member, National Academy of Sciences, USA
BIT's World Cancer Congress 2008 looks for ward to welcoming you to Shanghai for a stimulating scientific program and memorable social events and looking for partners for the common wealth
of World Cancer Congress. Interested in to learn more or sponsor the congress? Join us Today!
PepCon-2008
(April 22-24, 2008, Shenzhen,China)
Industrial Biotechnology, 2008
(May 18-22, 2008, Hangzhou, China)
WSA-2008
(July 20-26, 2008, Kunming, China)
Bio-Venture Capital Forum
(Oct. 11-15, 2008, Dalian, China)
IDDST 2008
(Oct.18-22, 2008, Beijing, China )
CEMD-2008
(Oct.22-28, 2008, Beijing & Xi'an, China)
RSWC 2008
(Oct.23-25, 2008, Beijing, China)
WCV 2008
(
Dec.1-5, 2008, Guangzhou, China)
WCG 2008
(Dec. 5-7, 2008, Guangzhou, China)
 
 
To bring together 30 Governmental Decision Makers and Leaders of Non-Profit  Organizations/Industries
To schedule 250-300 scientific and technological presentations by world leading Scientists and  Executives on the Anti-Cancer Biomarkers, Mechanisms, diagnostic,  medications and cancer  management.
To cover 6 Cancer Training Courses for Doctors, Nurses and Public.
To initiate 3 Anti-Cancer public awareness activities
To integrate 2-3 cultural and art events from Art and Culture Group such as from Celebrities.
To organize fund raising and Therapeutics donation activities for Non-Profit Research Centers or Hospitals.
To celebrate the fifty years of the discovery of Estrogen Receptor, we will organize a commemorate symposium during the World Cancer Congress as below:

 
The BIT's Annual World Cancer Congress is a China-based, interactive conference providing practicing oncologists with the latest basic research on cancer pathogen mechanisms, therapeutics development, clinical data, best practices, and new technologies that are directly applicable to the practice of cancer research and therapeutic discovery and development..

The 2008 cancer congress program will include the following fields:
 
Gain Insights from parallel sessions
 
The conference features with a cluster of sessions on broad subjects of both specific and general interests in cancer R & D. More than 350 scientists and clinicians will come to the board to share the new findings and breakthroughs to accelerate the modern cancer research and anticancer therapeutic development.
 
 
Explore Public Awareness
 
To raise public awareness of cancer and represent the concerns and interests in global breast cancer prevention and care to all the representatives; pressing for better physical and psychological care and treatment as well as increased reso-urces to support cancer researches.
 
 
Learn from Training Course
 

The courses will focus on the practical applications of epidemiological principles and therapeutic methods in the various activities of cancer control, understand-ing the causes of cancer incidence to the implementation and evaluation of treat-ment approaches

 
 
Benefit from Poster Review
 
If you want to share your interesting achievement update with our colleagues at the congress, please submit individually or collectively a poster for the presentation in a definite area depicted in the program. For submission requirement, please check with the poster guideline...
 

Your Best Practices to Share Your colleagues
Reasons You Should Share Your Research at World Cancer Congress:
Download Call for Posters PDF information file.
---------------------------
Download the Call for Posters submission form in Microsoft Word format.
Poster competition with Outstanding Poster Award
Receive $50 off your registration fee
Your poster abstract will be published on the conference proceedings
Your research will be seen by a cross section of scientists and leaders from top academic, healthcare, pharmaceutical, and biotech institutes

The World Cancer Congress is scheduled During June 12-17, 2008 at Everbright Convention & Exhibition Center in Shanghai, China. This meeting will be a dynamic forum for all scientists, oncologist, investigator,
clinicians, Healthcare colleagues, executives, leaders around the world who are actively involved in cancer research and therapeutics development, including basic, transla-tional, clinical, epidemiologic, prevention, diagnosis and drug discovery and develop-ment. The conference will provide participants a face-to-face platform to exchange ideas, share update breakthroughs and promising solutions to most important issues in the area.
For more information about the deadline on submission of papers and speech abstracts, or want to have poster and exhibition, please click here
We hope you will enjoy the exciting scientific program and culture events along the tech tour that will bring together experts and participants to represent the strength and diversity in all fields of cancer researches as well as the strategies for cancer diagnostics and tomorrow cancer therapeutics.
We're looking for strategic partners to 2008 BIT's World Cancer Congress. If you are interested in sponsoring the congress or being a media partner, please contact us Now!

Below of a few sites of our past conferences:

©2008 All right reserved for BIT Life Sciences
 
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84799629